IPO value of select CAR-T companies 2013-2015
This statistic shows IPO values of selected companies with a CAR-T (chimeric antigen receptor T-cell) focus between 2013 and 2015. Kite Pharma had an IPO value of 128 million U.S. dollars in June 2014.